A HER2-targeting antibody-MMAE conjugate RC48 sensitizes immunotherapy in HER2-positive colon cancer by triggering the cGAS-STING pathway

Human epidermal growth factor receptor 2 (HER2) is a protein that is overexpressed in some types of cancer, including breast and urothelial cancer. Here we found that HER2 was present in a portion of colon cancer patients, raising the possibility of using anti-HER2 therapy. RC48, a novel antibody-dr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaohan, Xu, Lingyan, Li, Xiaofei, Zhou, Yirui, Han, Xiao, Zhang, Wei, Wang, Weicheng, Guo, Wenjie, Liu, Wen, Xu, Qiang, Gu, Yanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449775/
https://www.ncbi.nlm.nih.gov/pubmed/37620320
http://dx.doi.org/10.1038/s41419-023-06073-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449775/
https://www.ncbi.nlm.nih.gov/pubmed/37620320
http://dx.doi.org/10.1038/s41419-023-06073-8

Ejemplares similares